Rationale drug design

/Rationale drug design
Rationale drug design 2019-01-08T16:45:46+00:00

In silico screening services. We count with a library of 500,000 fragment compounds to test on protein target structures. Our silico screening protocol, which has a 10% to 20% hit rate, employs proprietary machine learning algorithms, together with protein conformational assessment, to perform the candidate compound selection.